<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>House Republicans probe CVS for alleged HIPAA violation — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">House Republicans probe CVS for alleged HIPAA violation</h2>
    <div class="badge">2025-09-08T10:05:44+00:00</div>
    <ul>
      <li>CVS operates 119 pharmacies in Louisiana, along with one of the largest PBMs in the nation.</li>
<li>358, a bill that would prevent companies in the state from operating both pharmacy benefit managers and pharmacies.</li>
<li>pharmaceutical supply chain.</li>
<li>This story was originally published on Healthcare Dive.</li>
<li>CVS denied that its actions represented a violation of HIPAA to the state.</li>
<li>The text threatened that local pharmacies would close and drug prices would rise if Louisiana were to pass H.B.</li>
<li>A spokesperson for CVS confirmed that the company has received the letter and plans to respond, while defending CVS’ behavior as “consistent with the law.” Dive Insight: The letter stems from reports that on June 11 CVS</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=House Republicans probe CVS for alleged HIPAA violation\n• CVS operates 119 pharmacies in Louisiana, along with one of the largest PBMs in the nation.\n• 358, a bill that would prevent companies in the state from operating both pharmacy benefit managers and pharmacies.\n• pharmaceutical supply chain.\n• This story was originally published on Healthcare Dive.\n• CVS denied that its actions represented a violation of HIPAA to the state.\n• The text threatened that local pharmacies would close and drug prices would rise if Louisiana were to pass H.B.\n• A spokesperson for CVS confirmed that the company has received the letter and plans to respond, while defending CVS’ behavior as “consistent with the law.” Dive Insight: The letter stems from reports that on June 11 CVS" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/m/2dcba3f2-4037-3427-bb54-c17a47a20e2f/house-republicans-probe-cvs.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>